NURECA

Nureca Share Price

 

 

Start SIP in NURECA

Start SIP

Performance

  • Low
  • ₹296
  • High
  • ₹316
  • 52 Week Low
  • ₹204
  • 52 Week High
  • ₹435
  • Open Price₹308
  • Previous Close₹311
  • Volume27,840
  • 50 DMA₹288.83
  • 100 DMA₹278.82
  • 200 DMA₹273.94

Investment Returns

  • Over 1 Month + 5.5%
  • Over 3 Month -6.23%
  • Over 6 Month + 16.23%
  • Over 1 Year -26.67%

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.1
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 299
  • P/B Ratio
  • 1.5
  • Average True Range
  • 14.74
  • EPS
  • 11.15
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.73
  • RSI
  • 51.86
  • MFI
  • 60.72

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹299.35
-11.2 (-3.61%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹297.78
  • 50 Day
  • ₹288.83
  • 100 Day
  • ₹278.82
  • 200 Day
  • ₹273.94

Resistance and Support

303.78 Pivot Speed
  • R3 331.42
  • R2 323.68
  • R1 311.52
  • S1 291.62
  • S2 283.88
  • S3 271.72

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 143.30 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 18% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 67 which is a FAIR score but needs to improve its earnings, a RS Rating of 76 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 134 indicates it belongs to a poor industry group of Medical-Products and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-17 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-11-28 Buy Back of Shares
2025-11-10 Buy Back of Shares
2025-10-16 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-07-15 Quarterly Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Nureca Dividend History Arrow

Nureca F&O

Nureca Shareholding Pattern

68.09%
0%
0%
0.09%
0%
29.73%
2.09%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹299 As on 22 January, 2026 | 08:14

The Market Cap of Nureca is ₹299.4 Cr As on 22 January, 2026 | 08:14

The P/E ratio of Nureca is 28.1 As on 22 January, 2026 | 08:14

The PB ratio of Nureca is 1.5 As on 22 January, 2026 | 08:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23